Login / Signup

Real-world Big-data: Strengths and weaknesses of ASCO's CancerLinQ® discovery multiple myeloma dataset.

Christin B DeStefanoJennifer A ThorntonSteven J GibsonKevin PhamRobert S MillerKevin Sunderland
Published in: American journal of hematology (2023)
Keyphrases
  • big data
  • multiple myeloma
  • small molecule
  • artificial intelligence
  • machine learning
  • high throughput